SCHEMBL3970478

SCHEMBL3970478

Cc1nc2ccc(N3CCN(C)CC3)cc2c(-c2ccc(F)cc2)c1CCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TNKS O95271 1/20 0.45
PARP1 P09874 1/20 0.45
TNKS2 Q9H2K2 1/20 0.45
IDO1 P14902 1/20 0.45
TDO2 P48775 1/20 0.45
IDO2 Q6ZQW0 1/20 0.45
HTR6 P50406 1/20 0.43
RPS6KA3 P51812 1/20 0.42
MAPT P10636 6/20 0.42
ALDH1A1 P00352 2/20 0.42
TP53 P04637 2/20 0.42
GAA P10253 1/20 0.42
MAPKAPK2 P49137 1/20 0.41
ADRA2A P08913 2/20 0.41
ADRA2C P18825 2/20 0.41
ACVR1 Q04771 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3962968 0.91 IDO1 (0.42) KDM4EIDO1TDO2IDO2MAPT
SCHEMBL3962208 0.83 HTR2A (0.47) KDM4ENPC1RAB9ASMN1; SMN2TNKS
SCHEMBL3961778 0.82 IDO1 (0.44) KDM4ENPC1RAB9AIDO1TDO2
SCHEMBL3964608 0.81 KDM4E (0.39) KDM4ENPC1RAB9ASMN1; SMN2TNKS
SCHEMBL13881617 0.81 KDM4E (0.46) KDM4ENPC1RAB9ASMN1; SMN2TNKS
SCHEMBL4146761 0.80 KDM4E (0.48) KDM4ENPC1RAB9ASMN1; SMN2TNKS
SCHEMBL3961796 0.78 RXFP1 (0.48) KDM4EALDH1A1
SCHEMBL3964828 0.76 KCNH2 (0.43) KDM4EIDO1TDO2IDO2MAPT
SCHEMBL3969490 0.75 KCNH2 (0.41) KDM4EMAPTALDH1A1
SCHEMBL3963734 0.74 DRD2 (0.45) KDM4EIDO1TDO2IDO2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009041904-A1 QUINOLINE COMPOUNDS HAVING AN ACTIVITY AGAINST THE GABAB RECEPTOR ASTRAZENECA AB (SE) 2009-04-02 WO disclosed